Immunotherapy for Egg Allergy Shows Promise in Long-Term Study

Researchers and clinicians in attendance at the annual American Academy of Allergy, Asthma, and Immunology (AAAAI) conference are readily cognizant to the widespread impact...

Top 10 Immuno-Oncology Startups

GlaxoSmithKline (GSK)’s recently announced $4.2 billion partnership to co-develop and co-commercialize Merck KGaA, Darmstadt’s cancer immunotherapy candidate M7824 was a reminder of just how...

Stroke Recovery May Be Assisted by HIV Drug, Suggests Study of...

Hints have been accumulating that maraviroc, a drug for slowing HIV, could benefit patients who have suffered mild stroke. A few years ago, maraviroc...

Triclosan Added to Consumer Products Dramatically Decreases Antibiotic Efficacy

New research finds a chemical that is supposed to kill bacteria is making them stronger and more capable of surviving antibiotic treatment. The study suggests that triclosan exposure may inadvertently drive bacteria into a state in which they are able to tolerate normally lethal concentrations of antibiotics.

Colorectal Cancer Stem Cell Growth Driven by High-Fat Diet and Altered...

Studies by Salk Institute scientists have suggested how high-fat diets may fuel the early development of colorectal cancer in people who have a common...

Cancer Immunotherapy BiTE Method May Identify Patients Who Will Benefit Most

Scientists at Osaka University and colleagues have revealed a correlation between the cancer cell-killing activity of T cells within tumors in lung cancer patients...

Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline

Merck & Co. said today it has agreed to acquire Immune Design for approximately $300 million, in a deal designed to boost the buyer’s...

Antibiotic Resistant Gene Blocked by Novel Combination Therapy

Scientists in Canada say they have found a method to block the VCC-1 enzyme, which disables the VCC-1 antimicrobial-resistance gene. VCC-1, a ß-lactamase gene, has been discovered in benign close relatives of virulent Vibrio cholerae, which causes cholera.

Flesh-Eating Bacteria’s Genomic/Transcriptomic Trigger Found

Coordinating the sort of full-spectrum analysis more commonly deployed in cancer research, scientists based at Houston Methodist examined flesh-eating strains of Streptococcus pyogenes both...

Novartis Creates “Inflection Point” for AbCellera with 10-Target Antibody Collaboration

Novartis will use AbCellera’s antibody discovery platform and single-cell screening technology to identify and develop up to 10 targets, through a collaboration whose value...

Recently Featured

Stay Connected

557,117FansLike
46,490FollowersFollow
Scroll Up